Reply to Letter to the Editor: 'Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease'

Anatol J Cardiol. 2023 Jan;27(1):56-58. doi: 10.14744/AnatolJCardiol.2022.2335.
No abstract available

MeSH terms

  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Kidney Diseases*

Substances

  • Anticoagulants